Target intelligence / Profile preview

Osmotic action in gut

Molecular classification
Other
01

Overview

"Osmotic action in gut" does not refer to a single molecule, receptor, enzyme, transporter or other discrete therapeutic target. Instead, it describes a physiological process whereby water is absorbed or secreted across the intestinal epithelium due to differences in osmolarity between the intestinal lumen and body fluids. This process is mediated by multiple ion channels and transporters—including Na⁺/K⁺ ATPase pumps (NKA), Na⁺/K⁺/2Cl⁻ cotransporters (NKCC2), Cl⁻ channels, aquaporins for water movement, and various bicarbonate transporters—rather than any one specific protein or receptor[1][2][3][4][6][7]. The coordinated activity of these proteins enables marine animals and humans alike to maintain fluid balance under varying environmental conditions. In clinical pharmacology and therapeutics—such as with "osmotic laxatives"—the term refers to drugs that increase luminal solute concentration so that water remains within the intestine via passive osmosis. These agents do not act on a unique molecular target but rather exploit this general physiological principle. Because "Osmotic action in gut" is not a canonical molecular entity but rather an emergent property of many interacting proteins/processes within enterocytes and their membranes[1][2], it should not be classified as a druggable target per se. If structured data are required for drug-target mapping or bioinformatics purposes, this entry should be flagged as incorrect/incomplete for those uses.

Other names
Osmotic action in gutIntestinal osmoregulationGut osmoregulatory process
02

Mechanism of action

Increase luminal osmolarity to draw water into the intestinal lumen by passive osmosis, promoting bowel movement and softening stool[5]

03

Biological functions

Water absorptionIon transportOsmoregulation
04

Disease associations

Other
05

Safety considerations

Dehydration (from excessive fluid loss)Electrolyte imbalance (especially with chronic or high-dose use of osmotic agents)
06

Interacting drugs

Polyethylene glycol (osmotic laxatives)

2 more in the full profile.

Beyond the preview

Go deeper on Osmotic action in gut.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Osmotic action in gut.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call